Linomide
CAS: 84088-42-6
Ref. 3D-JDA08842
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
Linomide
Sinónimos:
- 1,2-Dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
- 1,2-Dihydro-4-hydroxy-N,N-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
- 2-hydroxy-N,1-dimethyl-4-oxo-N-phenyl-1,4-dihydroquinoline-3-carboxamide
- 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-
- 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
- Abr 212616
- Fcf 89
- Ls 2616
- N-Methyl-N-phenyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide
- Pnu 212616
- Ver mais sinónimos
- Roquinimex
Descrição:
Linomide is a drug that inhibits the angiogenic process and prevents the growth of cancer cells. It has been shown to be effective against renal cell cancer in vitro assays and in animal models. Linomide is also effective against autoimmune diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease. In vitro assays have shown that linomide can inhibit the growth of several types of human cancers, including breast cancer, prostate cancer, and bowel cancer. This drug has also been shown to be an inhibitor of basic fibroblast growth factor (bFGF) receptor kinase activity and neuronal death.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
308.34 g/mol
Fórmula:
C18H16N2O3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
